09.10.2013 14:36:12

Pre-market Movers For Oct 9 (AA, MW, JOSB, FDO, ARIA, LXRX, ICPT, FAST)

(RTTNews) - Gainers:

Alcoa Inc. (AA) is rising 3 percent to $8.18. The company swung to a profit in its third quarter. Revenues for the quarter declined from the year-ago quarter due mainly to weak metal prices, but topped the consensus estimate. The company also said it continues to expect global aluminum demand growth of 7 percent for 2013.

Men's Wearhouse, Inc. (MW) is gaining 33 percent to $46.80 based on the news that JoS. A. Bank Clothiers, Inc. (JOSB) has made a non-binding proposal to acquire the company for $48 per share in cash, representing a total equity value of about $2.3 billion, in a negotiated transaction. JOSB is rising 10 percent to $45.70.

Decliners:

Family Dollar Stores Inc. (FDO) is falling 3 percent to $67.25. The company's fourth quarter profit and net sales improved from the prior year period. The company guided first quarter earnings below Street view and issued a cautious outlook for fiscal 2014.

Ariad Pharmaceuticals Inc. (ARIA) is plunging 59 percent to $7.02 following the news that the FDA has placed a partial clinical hold on all new patient enrollment in clinical trials of Iclusig. The company said the patient enrollment in all trials of Iclusig is being paused, and would be resumed with expected changes in dose and other modifications.

Lexicon Pharmaceuticals, Inc. (LXRX) is down 7 percent to $2.50. The company announced top-line results from a pilot study exploring the use of telotristat etiprate in ulcerative colitis. The company said that in this pilot study of mild to moderate ulcerative colitis, telotristat etiprate achieved the primary objective of demonstrating safety and tolerability. Although these results provide a clear signal of activity of the mechanism of action of telotristat etiprate in this patient population, they were not accompanied by other findings that would indicate a large impact on disease modification, the company noted.

Intercept Pharmaceuticals, Inc. (ICPT) is down 3 percent to $62.20. The company announced the pricing of a public offering of 1.50 million shares of its common stock by certain selling stockholders at $62.50 per share.

Fastenal Co. (FAST) is down 5 percent to $47.50. The company's third quarter results were below Wall Street view.

Nachrichten zu Ariad Pharmaceuticals Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Ariad Pharmaceuticals Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Fastenal Co. 78,61 -0,87% Fastenal Co.